STOCK TITAN

Alkermes to Report First Quarter Financial Results on May 1, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Alkermes plc (Nasdaq: ALKS) will discuss its first quarter financial results in a conference call and webcast on May 1, 2024. Investors can access the webcast and slides on the company's website. The conference call details are provided for U.S. and international callers.
Alkermes plc (Nasdaq: ALKS) discuterà i risultati finanziari del primo trimestre in una teleconferenza e trasmissione web il 1 maggio 2024. Gli investitori possono accedere alla trasmissione web e alle slide sul sito web dell'azienda. I dettagli della teleconferenza sono disponibili per i partecipanti dagli Stati Uniti e internazionali.
Alkermes plc (Nasdaq: ALKS) discutirá los resultados financieros del primer trimestre en una llamada de conferencia y transmisión web el 1 de mayo de 2024. Los inversores pueden acceder a la transmisión web y a las diapositivas en el sitio web de la compañía. Los detalles de la llamada de conferencia están disponibles para los participantes de EE. UU. y de otros países.
Alkermes plc (나스닥: ALKS)는 2024년 5월 1일에 웹캐스트와 컨퍼런스 콜을 통해 첫 번째 분기 재무 결과를 논의할 예정입니다. 투자자들은 회사 웹사이트에서 웹캐스트와 슬라이드에 접근할 수 있습니다. 컨퍼런스 콜의 세부사항은 미국 및 국제 참가자들을 위해 제공됩니다.
Alkermes plc (Nasdaq : ALKS) discutera de ses résultats financiers du premier trimestre lors d'une conférence téléphonique et d'une webdiffusion le 1er mai 2024. Les investisseurs peuvent accéder à la webdiffusion et aux diapositives sur le site web de l'entreprise. Les détails de la conférence téléphonique sont fournis pour les appelants des États-Unis et internationaux.
Alkermes plc (Nasdaq: ALKS) wird seine Finanzergebnisse für das erste Quartal in einem Telefonkonferenz und Webcast am 1. Mai 2024 besprechen. Investoren können den Webcast und die Folien auf der Unternehmenswebsite abrufen. Die Details des Telefonkonferenz sind für Teilnehmer aus den USA und international verfügbar.
Positive
  • None.
Negative
  • None.

DUBLIN, April 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, May 1, 2024 to discuss the company's first quarter financial results.

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes' website at www.alkermes.com. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes' website. 

About Alkermes plc

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-first-quarter-financial-results-on-may-1-2024-302119806.html

SOURCE Alkermes plc

FAQ

When will Alkermes report its first quarter financial results?

Alkermes will report its first quarter financial results on May 1, 2024.

Where can investors access the webcast and slides for the financial results discussion?

Investors can access the webcast and slides on Alkermes' website at www.alkermes.com.

How can U.S. callers join the conference call for the financial results discussion?

U.S. callers can dial +1 877 407 2988 to join the conference call.

How can international callers join the conference call for the financial results discussion?

International callers can dial +1 201 389 0923 to join the conference call.

Alkermes Inc. plc

NASDAQ:ALKS

ALKS Rankings

ALKS Latest News

ALKS Stock Data

4.06B
158.79M
1.25%
108.01%
8.58%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
DUBLIN 4

About ALKS

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.